(1 - 29 von 32
)
Gene therapy increases factor IX activity in severe hemophilia B - Healio
www.healio.com
... [for] immune responses that require immunosuppression or may lead to a loss of efficacy,” Matt Kapusta, CEO of uniQure, said in the release.
uniQure Receives Frost & Sullivan Manufacturing Leadership Award
www.firmenpresse.de
-- Lexington, MA-based Gene Therapy Facility Recognized for Enabling Manufacturing Excellence --LEXINGTON, Mass
uniQure N.V.: uniQure Appoints Alexander Kuta as Senior Vice...
www.finanznachrichten.de
He will report to Matt Kapusta, Chief Executive Officer of uniQure, and will be based in the Company's Lexington, Massachusetts facility. "Alex has an accomplished track …
uniQure Receives Frost & Sullivan Manufacturing Leadership Award...
www.wallstreet-online.de
... in gene therapy and we are delighted that Frost & Sullivan has recognized our achievements in this regard," stated Matt Kapusta, chief executive officer of uniQure. …
uniQure N.V.: uniQure Announces Company Participation at Citi...
www.finanznachrichten.de
Matt Kapusta, chief executive officer of uniQure, will participate on the analyst-moderated panel entitled, "Gene-Therapy Manufacturing and ...
uniQure Appoints Alexander Kuta as Senior Vice President of...
www.bionity.com
uniQure N.V. announced the appointment of Alexander Kuta, Ph.D., as Senior Vice President of Regulatory Affairs. Dr. Kuta has more than 25 years of regulatory...
Burr and Burton Academy | Bulldogs loss a close game at home
www.burrburton.org
The Bulldogs where home at the E.H. Henry Gymnasium on Saturday Feb 17th and they were hosting a Good St. Johnsbury Hilltopper team that beat the Jv Gold 9...
Burr and Burton Academy | Bulldogs push winning streak to 4 game
www.burrburton.org
The Jv Gold Bulldogs took the short drive over the mountain Monday night to play the Green Mountain high school chieftains.It was a great game played by both...
FDA OKs Clinical Study of AMT-130 Gene Therapy in Huntington’s disease
huntingtonsdiseasenews.com
Read about how uniQure is launching a Phase 1/2 clinical trial to evaluate its Huntington’s disease investigational gene therapy, AMT-130.
Burr and Burton Academy | Bulldogs lose a tough one
www.burrburton.org
The Burr and Burton Jv gold team came up on the short end of the scoreboard on Wednesday afternoon at the Granville american legion basketball tournament. The...
E-Malt: E-Malt.com News article: USA, GA: Abide Brewing Company...
www.e-malt.com
He and two friends, Philip Leonard and Matt Kapusta, brewed as a hobby and always dreamed of taking their craft to a professional level.
EMA designates uniQure's gene therapy for hemophilia a priority
www.labiotech.eu
Following a Fast Track Designation from the FDA earlier this year, the Dutch biotech has scored the European equivalent for AMT-060.
Goodbye Glybera! The World's First Gene Therapy will be Withdrawn
www.labiotech.eu
The excitement about the therapy was undercut when it became clear Glybera would be a commercial failure. In October, it will officially be dead.
Hemophilia B Gene Therapy AMT-060 Moves to Large-scale Production,...
hemophilianewstoday.com
Read about uniQure, which has improved the manufacturing platform of its hemophilia B gene therapy AMT-060, in accordance with Good Manufacturing Practices.
Dutch Life Science Database
www.dutchlifescience.com
Search the Dutch Life Science Database and identify potential partners in the Dutch Biotech, Pharma and Medtech industry
UniQure Escalates Hemophilia B Gene Therapy Manufacturing Site |...
www.hemophilia.org
UniQure N.V. has announced that is has “scaled up” the manufacturing process at its large facility in Lexington, MA.
Forum: uniQure » Hemophilia A and B | Beursduivel.be
www.beursduivel.be
To understand why we talked with Matt Kapusta, CEO of uniQure, a Dutch biotech leading its development. “It proved to be a strong and ...
NewsDiffs | Diffing: New Gene-Therapy Treatments Will Carry Whopping...
newsdiffs.org
NewsDiffs tracks changes in online news articles over time
PG South: Bethel volleyball team on verge of making history |...
www.post-gazette.com
The Bethel Park High School boys' volleyball team has a chance to go where no previous Black Hawks team has gone. ...
UniQure gets speedy US review for Huntington's gene therapy - PMLiVEwww.pmlive.com › pharma_news › uniqure_gets_spe...
www.pmlive.com
Matt Kapusta. “Achieving fast track designation from the FDA underscores the high unmet medical need for patients suffering from Huntington's ...
Uniqure turns the screw on Spark and Pfizer | Evaluate
www.evaluate.com
In the race to develop a haemophilia B gene therapy Uniqure now has the upper hand.
uniQure Announces First Patient Treated in HOPE-B Pivotal Trial of...
www.hemophiliafed.org
“Our mission in hemophilia B has always been to be first to market with a best-in-class gene therapy,” said Matt Kapusta, chief executive officer.
uniQure Receives FDA Fast Track Designation for AMT European...
european-biotechnology.com
Following the FDA granted AMT-130 fast track designation, uniQure NV announced it will start Phase I/II testing of the Huntington’s Disease gene therapy in...
uniQure appoints Alexander Kuta as Senior Vice President of...
www.manufacturingchemist.com
He will report to Matt Kapusta, Chief Executive Officer of uniQure, and will be based in the Company's Lexington, Massachusetts facility.
uniQure to Participate in Multiple Upcoming Industry
www.globenewswire.com
Matt Kapusta and Sander van Deventer will attend and participate in investor meetings at the conference on Thursday, September 5.
uniQure : Announces Management and Board Changes | MarketScreener
www.marketscreener.com
Lexington, MA and Amsterdam, the Netherlands, September 22, uniQure N.V. , a leader in human gene therapy, today announced that its Board of Directors...
uniQure Announces Management and Board Changes
www.globenewswire.com
LEXINGTON, Mass. and AMSTERDAM, The Netherlands, Sept. ...
uniQure Announces Leadership Team Appointments and
www.globenewswire.com
-- Scott McMillan Named Chief Operating Officer Sander van Deventer Named Chief Scientific Officer, General Manager, Amsterdam Christian...
uniQure To Present At NewsMakers In The Biotech Industry Conference -...
www.biospace.com
uniQure To Present At NewsMakers In The Biotech Industry Conference - NYC - read this article along with other careers information, tips and advice on BioSpace
sortiert nach Relevanz / Datum